Overview of Libtayo, First New FDA-Approved Drug for Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

Overview of Libtayo, First FDA-Approved Drug for Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) When Surgery or Radiation Isn’t an Option

Susan (Sue) Treiman is an award-winning newspaper reporter, television producer, website executive, and corporate communications expert. She is passionate about writing on health, medicine, and wellness. She has been published in every New York City newspaper, produced television programs for ABC News, CBS News, and Paramount Pictures, headed up the editorial work on ABC’s original flagship website, ABC.com, and launched the network’s first children’s website.

More recently, Treiman has served as the in-house journalist for several international management consulting firms. At Everyday Health, she has written about women’s health, stress, sleep medicine, and psychology, and has written for various other publications, including Linkwell Health and In the Groove.

Treiman is based in New York, and is an abstract artist who enjoys painting in her free time.